<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01764282</url>
  </required_header>
  <id_info>
    <org_study_id>2012ZX10001007-001</org_study_id>
    <nct_id>NCT01764282</nct_id>
  </id_info>
  <brief_title>Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission</brief_title>
  <official_title>A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for AIDS/STD Control and Prevention, China CDC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for AIDS/STD Control and Prevention, China CDC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among
      sero-discordant couples by applying comprehensive intervention components.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cluster-randomized controlled trial was carried out in forty counties from 16 cities. The
      strategy of Social Marketing was applied to influence sero-discordant couples' behavioral
      changes including safer sexual intercourses, regular HIV testing for the negative partners,
      antiretroviral therapy initiation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HIV seroconversion rate of HIV negatives among HIV serodiscordant couples</measure>
    <time_frame>up to 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of HIV positives receiving ART among HIV serodiscordant couples</measure>
    <time_frame>up to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples</measure>
    <time_frame>up to 2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11096</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>comprehensive intervention components</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>According the National HIV Antiretroviral treatment Guideline, provide treatment referrals for those treatment-eligible HIV-positive patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>comprehensive intervention components</intervention_name>
    <description>ART promotion, Couple testing and consulting promotion, and Condom use promotion</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Couples are required to have a stable relationship and live together in the last 3
             months;

          -  Older than 18 years and younger than 60 years; without regard to CD4 count;

          -  Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment
             will be included during the study period).

        Exclusion Criteria:

          -  Couples are not have a stable relationship or do not live together in the last 3
             months;

          -  Younger than 18 years old.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zuyou Wu, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Center for AIDS/STD Control and Prevention, China CDC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Nanning, Guilin, Laibin, Qinzhou</city>
        <state>Guangxi</state>
        <zip>530028</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Disease Control and Prevention, Henan Province</name>
      <address>
        <city>Zhumadian</city>
        <state>Henan</state>
        <zip>463000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Disease Control and Prevention, Sichuan Province</name>
      <address>
        <city>Liangshan</city>
        <state>Sichuan</state>
        <zip>615000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region</name>
      <address>
        <city>Urumchi, Ili</city>
        <state>Xinjiang</state>
        <zip>830002</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Disease Control and Prevention, Yunnan Province</name>
      <address>
        <city>Kunming, Dehong, Wenshan, Honghe</city>
        <state>Yunnan</state>
        <zip>650022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.nmp.gov.cn/index.htm</url>
    <description>National Science and Technology Project</description>
  </link>
  <results_reference>
    <citation>Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011 Jul;11(7):516-24. doi: 10.1016/S1473-3099(11)70097-4.</citation>
    <PMID>21600849</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 May 15;50 Suppl 3:S85-95. doi: 10.1086/651478. Review.</citation>
    <PMID>20397961</PMID>
  </results_reference>
  <results_reference>
    <citation>Stephenson R, Barker J, Cramer R, Hall MA, Karita E, Chomba E, Vwalika C, Allen S. The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia. AIDS Care. 2008 Mar;20(3):395-405. doi: 10.1080/09540120701593497.</citation>
    <PMID>18351489</PMID>
  </results_reference>
  <results_reference>
    <citation>He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, Yang Y, Wang J, Montaner JS, Wu Z; China National HIV Prevention Study Group. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013 Nov 13;8(11):e77981. doi: 10.1371/journal.pone.0077981. eCollection 2013.</citation>
    <PMID>24236010</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2013</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>serodiscordant couples HIV sero-conversion</keyword>
  <keyword>anti-retroviral therapy</keyword>
  <keyword>intervention</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

